A common CORIN variant in hypertension reduces corin intracellular trafficking by exposing an inhibitory N-terminus

Meiling He,Yue Zhang,Hui Li,Meng Liu,Ningzheng Dong,Qingyu Wu
DOI: https://doi.org/10.1016/j.bbrc.2020.07.023
IF: 3.1
2020-09-01
Biochemical and Biophysical Research Communications
Abstract:<p>Corin is a transmembrane serine protease that activates atrial natriuretic peptide, a cardiac hormone essential for normal blood pressure. Corin is synthesized as a zymogen and activated on the cell surface. In previous studies, we identified a <em>CORIN</em> variant allele with an adenine insertion in the 5′-end of the coding region in ∼5% of hypertensive individuals in a Chinese population. The protein, named insA, encoded by the <em>CORIN</em> variant allele has a shortened cytoplasmic tail and reduced atrial natriuretic peptide processing activity. It remains unknown how a shortened cytoplasmic tail impairs corin function. In this study, we expressed a series of corin mutants with different N-terminal sequences and analyzed them by Western blotting, flow cytometry, protein chase, and immunostaining. Our results revealed that a Gly-Asn sequence after the initiating Met at the newly generated N-terminus was responsible for delaying corin trafficking in the Golgi. Deletion of the N-terminal Gly and Asn residues increased the intracellular trafficking, cell surface expression, and activation cleavage of the insA variant. These results help to explain how the <em>CORIN</em> variant allele impairs corin structure and function as an underlying mechanism in hypertension.</p>
biochemistry & molecular biology,biophysics
What problem does this paper attempt to address?